CRB1 and retinal disorder: Reductions in antioxidants and neuroprotective agents were found alongside energy metabolism dysregulation.<h4>Conclusion</h4>These findings reveal metabolic dysregulation in CRB1-retinopathy, including altered gut microbiome-related metabolic activity, and no strong metabolomic evidence of severe intestinal barrier disruption.